C

Corcept Therapeutics
D

CORT

73.960
USD
-14.41
(-16.31%)
مغلق
حجم التداول
126,896
الربح لكل سهم
1
العائد الربحي
-
P/E
67
حجم السوق
7,793,293,077
أصول ذات صلة الأخبار المقالات

العنوان: Corcept Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.